PCH Regimen

Known as: Paclitaxel-Carboplatin-Herceptin Regimen 
A sequential regimen consisting of carboplatin and paclitaxel, followed by trastuzumab, used in the adjuvant setting for the treatment of HER-2/neu… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
0120132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare causes of pulmonary… (More)
Is this relevant?
2018
2018
Objective: To improve the diagnosis and treatment of the pulmonary veno-occlusive disease (PVOD) and pulmonary capillary… (More)
Is this relevant?
Review
2018
Review
2018
Pulmonary veno-occlusive disease (PVOD)/pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary vascular disease… (More)
Is this relevant?
2017
2017
BACKGROUND Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are categorized as Group 1' in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2013
2013
Plasma cell hepatitis (PCH), also known as "de novo autoimmune" hepatitis, is an increasingly recognized, but suboptimally named… (More)
Is this relevant?